Browsing Tag
SUBLOCADE
2 posts
Why addiction treatment companies like Indivior are re-anchoring corporate control in the U.S.
Find out why Indivior’s U.S. redomiciliation signals a broader strategic shift across addiction treatment and regulated healthcare companies.
Indivior (Nasdaq: INDV) study supports 300 mg SUBLOCADE dose for fentanyl-heavy opioid use cases
Indivior’s new trial results highlight how higher-dose SUBLOCADE may better support fentanyl users in OUD treatment. See what this means for the industry.